The American Gastroenterological Association (AGA) has released an expert review and clinical practice update focusing on esophageal dysfunction caused by immune-mediated and infectious diseases.

approval by the U.S. Food and Drug Administration for its redesigned esolution ® esophageal deviation device, has begun its commercial launch starting in the United States. S4 has the first and ...